GFT505
GFT505 (Elafibranor) is a novel liver-targeted peroxisome proliferator-activated receptor alpha/delta (PPARα/δ) agonist. Displays anti-diabetic effects in db/db mice.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog